Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in J Am Geriatr Soc

Retrieve available abstracts of 30 articles:
HTML format
Text format



Single Articles


    November 2018
  1. VASSILAKI M, Aakre JA, Kremers WK, Mielke MM, et al
    Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia.
    J Am Geriatr Soc. 2018 Nov 21. doi: 10.1111/jgs.15577.
    PubMed     Text format     Abstract available


  2. GRIMMER T, Licata A
    Functional Decline in Alzheimer's Disease: A Continuum.
    J Am Geriatr Soc. 2018 Nov 21. doi: 10.1111/jgs.15668.
    PubMed     Text format    


    October 2018
  3. ROITTO HM, Kautiainen H, Ohman H, Savikko N, et al
    Relationship of Neuropsychiatric Symptoms with Falls in Alzheimer's Disease - Does Exercise Modify the Risk?
    J Am Geriatr Soc. 2018 Oct 15. doi: 10.1111/jgs.15614.
    PubMed     Text format     Abstract available


  4. MARCUM ZA, Walker R, Bobb JF, Sin MK, et al
    Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study.
    J Am Geriatr Soc. 2018 Oct 5. doi: 10.1111/jgs.15581.
    PubMed     Text format     Abstract available


    September 2018
  5. LILAMAND M, Cesari M, Cantet C, Payoux P, et al
    Relationship Between Brain Amyloid Deposition and Instrumental Activities of Daily Living in Older Adults: A Longitudinal Study from the Multidomain Alzheimer Prevention Trial.
    J Am Geriatr Soc. 2018 Sep 12. doi: 10.1111/jgs.15497.
    PubMed     Text format     Abstract available


    August 2018
  6. LIAO KF, Chuang HY, Lai SW
    Association Between Proton Pump Inhibitor Use and Alzheimer's Disease in Older Adults.
    J Am Geriatr Soc. 2018 Aug 10. doi: 10.1111/jgs.15474.
    PubMed     Text format    


  7. GOLDSTEIN FC
    Reply to: Association Between Proton Pump Inhibitors and Alzheimer's Disease in Older Adults.
    J Am Geriatr Soc. 2018 Aug 10. doi: 10.1111/jgs.15498.
    PubMed     Text format    


    May 2018
  8. OLTRA-CUCARELLA J, Sanchez-SanSegundo M, Lipnicki DM, Sachdev PS, et al
    Using Base Rate of Low Scores to Identify Progression from Amnestic Mild Cognitive Impairment to Alzheimer's Disease.
    J Am Geriatr Soc. 2018 May 10. doi: 10.1111/jgs.15412.
    PubMed     Text format     Abstract available


    April 2018
  9. DEHN LB, Boedeker S, Nienhaus M, Labudda K, et al
    Whether to Ask: How Valid Are Memory Complaints in Alzheimer's Disease?
    J Am Geriatr Soc. 2018 Apr 27. doi: 10.1111/jgs.15373.
    PubMed     Text format    


    March 2018
  10. KHANDKER RK, Black CM, Xie L, Kariburyo MF, et al
    Analysis of Episodes of Care in Medicare Beneficiaries Newly Diagnosed with Alzheimer's Disease.
    J Am Geriatr Soc. 2018 Mar 30. doi: 10.1111/jgs.15281.
    PubMed     Text format     Abstract available


  11. VAUGHAN RM, Coen RF, Kenny R, Lawlor BA, et al
    Semantic and Phonemic Verbal Fluency Discrepancy in Mild Cognitive Impairment: Potential Predictor of Progression to Alzheimer's Disease.
    J Am Geriatr Soc. 2018 Mar 23. doi: 10.1111/jgs.15294.
    PubMed     Text format     Abstract available


    February 2018
  12. FAES K, Cohen J, Annemans L
    Resource Use During the Last 6 Months of Life of Individuals Dying with and of Alzheimer's Disease.
    J Am Geriatr Soc. 2018 Feb 15. doi: 10.1111/jgs.15287.
    PubMed     Text format     Abstract available


    January 2018
  13. PANZA GA, Taylor BA, MacDonald HV, Johnson BT, et al
    Can Exercise Improve Cognitive Symptoms of Alzheimer's Disease? A Meta-Analysis.
    J Am Geriatr Soc. 2018 Jan 24. doi: 10.1111/jgs.15241.
    PubMed     Text format     Abstract available


    September 2017
  14. TRICCO AC, Ashoor HM, Soobiah C, Rios P, et al
    Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer's Disease: Systematic Review and Network Metaanalysis.
    J Am Geriatr Soc. 2017 Sep 29. doi: 10.1111/jgs.15069.
    PubMed     Text format     Abstract available


  15. CHENG HT, Lin FJ, Erickson SR, Hong JL, et al
    The Association Between the Use of Zolpidem and the Risk of Alzheimer's Disease Among Older People.
    J Am Geriatr Soc. 2017 Sep 7. doi: 10.1111/jgs.15018.
    PubMed     Text format     Abstract available


  16. GOLDSTEIN FC, Steenland K, Zhao L, Wharton W, et al
    Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia.
    J Am Geriatr Soc. 2017;65:1969-1974.
    PubMed     Text format     Abstract available


    August 2017
  17. ISAACSON R
    Is Alzheimer's Prevention Possible Today?
    J Am Geriatr Soc. 2017 Aug 28. doi: 10.1111/jgs.15060.
    PubMed     Text format    


  18. MEHTA N, Rodrigues C, Lamba M, Wu W, et al
    Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example.
    J Am Geriatr Soc. 2017 Aug 18. doi: 10.1111/jgs.15020.
    PubMed     Text format     Abstract available


  19. SANO M, Zhu CW, Grossman H, Schimming C, et al
    Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data.
    J Am Geriatr Soc. 2017 Aug 3. doi: 10.1111/jgs.15014.
    PubMed     Text format     Abstract available


  20. GALVIN JE
    Prevention of Alzheimer's Disease: Lessons Learned and Applied.
    J Am Geriatr Soc. 2017 Aug 2. doi: 10.1111/jgs.14997.
    PubMed     Text format     Abstract available


    July 2017
  21. CANEVELLI M, Cesari M, Lucchini F, Valletta M, et al
    Need to Recalibrate Research Outcomes in Alzheimer's Disease: Focus on Neuropsychiatric Symptoms.
    J Am Geriatr Soc. 2017 Jul 6. doi: 10.1111/jgs.14989.
    PubMed     Text format     Abstract available


    June 2017
  22. FARIAS ST, Lau K, Harvey D, Denny KG, et al
    Early Functional Limitations in Cognitively Normal Older Adults Predict Diagnostic Conversion to Mild Cognitive Impairment.
    J Am Geriatr Soc. 2017;65:1152-1158.
    PubMed     Text format     Abstract available


  23. SHAFI MM, Santarnecchi E, Fong TG, Jones RN, et al
    Advancing the Neurophysiological Understanding of Delirium.
    J Am Geriatr Soc. 2017;65:1114-1118.
    PubMed     Text format     Abstract available


    May 2017
  24. CALLAHAN CM
    Alzheimer's Disease: Individuals, Dyads, Communities, and Costs.
    J Am Geriatr Soc. 2017 May 5. doi: 10.1111/jgs.14808.
    PubMed     Text format     Abstract available


  25. BERGERON D, Flynn K, Verret L, Poulin S, et al
    Multicenter Validation of an MMSE-MoCA Conversion Table.
    J Am Geriatr Soc. 2017;65:1067-1072.
    PubMed     Text format     Abstract available


    April 2017
  26. EZZATI A, Wang C, Lipton RB, Altschul D, et al
    Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology.
    J Am Geriatr Soc. 2017 Apr 13. doi: 10.1111/jgs.14903.
    PubMed     Text format     Abstract available


    March 2017
  27. CAMPBELL NL, Perkins AJ, Gao S, Skaar TC, et al
    Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial.
    J Am Geriatr Soc. 2017 Mar 14. doi: 10.1111/jgs.14827.
    PubMed     Text format     Abstract available


    January 2017
  28. CHEN LH, Fan YH, Kao PY, Ho DT, et al
    Genetic Polymorphisms in Estrogen Metabolic Pathway Associated with Risks of Alzheimer's Disease: Evidence from a Southern Chinese Population.
    J Am Geriatr Soc. 2017 Jan 19. doi: 10.1111/jgs.14537.
    PubMed     Text format     Abstract available


    November 2016
  29. S VANN A
    Reporting Deaths of Individuals with Alzheimer's Disease.
    J Am Geriatr Soc. 2016 Nov 8. doi: 10.1111/jgs.14555.
    PubMed     Text format    


  30. DING X, Kryscio RJ, Turner J, Jicha GA, et al
    Self-Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial.
    J Am Geriatr Soc. 2016 Nov 1. doi: 10.1111/jgs.14393.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: